Insider Buying Spurs Confidence in SCINAI’s Low‑Cap Biotech
Insider buying at SCINAI signals confidence in its low‑cap inflammation biotech—executives’ stake rises amid market skepticism and future pipeline prospects.
- SCINAI IMMUNOTHERAPEUTICS LT
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read